Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Pipeline Insight: Schizophrenia' returned 61 results - Page 1 of 4   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Global Schizophrenia Drug Pipeline Capsule - 2012   Fore Pharma, Jan 2012, Pages: 14 : Overview - Schizophrenia Drug Pipeline Overview - Schizophrenia Phase 3 Clinical Trial Drug Pipeline Insights - Schizophrenia Phase 2 Clinical Trial Drug Pipeline Insights - Schizophrenia Phase 1 Clinical Global Schizophrenia Drug Pipeline Capsule - 2011   Fore Pharma, Aug 2011, Pages: 14 : Overview - Schizophrenia Drug Pipeline Overview - Schizophrenia Phase 3 Clinical Trial Drug Pipeline Insights - Schizophrenia Phase 2 Clinical Trial Drug Pipeline Insights - Schizophrenia Phase 1 Clinical Global Schizophrenia Therapeutics Market: Market Forecast, Patient Flow, Competitive Landscape, and Pipeline Analysis   Commercial Insights, May 2011, Pages: 114 and forecast by geography - Insights into market events that impact the schizophrenia therapeutics market by geography - Leading therapies by geography Competitive Landscape Analysis: - Market share insights Schizophrenia Therapeutics Market in the US: Market Forecast, Patient Flow, and Competitive Landscape   Commercial Insights, May 2011, Pages: 73 Years (2010 to 2018) Market Analysis: - Schizophrenia therapeutics market size and forecast – Global and the US - Insights into market events that impact the schizophrenia therapeutics market – The US Seroquel - Analysis and Estimates from 2002 to 2020   GlobalData, July 2011, Pages: 32 markets - Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets 1 1 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Schizophrenia 2 Schizophrenia - Pipeline Assessment and Market Forecast to 2017   GlobalData, Dec 2010, Pages: 50 , the report provides valuable insights on the pipeline products within the global Schizophrenia sector. This report is built using data and information sourced from proprietary databases, primary and secondary Saphris - Analysis and Estimates from 2009 to 2020   GlobalData, July 2011, Pages: 25 -2020). The report also includes information on Schizophrenia market. This report is built using data and information sourced from GlobalData’s proprietary databases, primary and secondary research using Company Cariprazine - Analysis and Forecasts from 2013 to 2020   GlobalData, July 2011, Pages: 26 markets - Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets 1 1 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Schizophrenia 2 Abilify - Analysis and Estimates from 2002 to 2020   GlobalData, July 2011, Pages: 32 markets - Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets 1 1 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Schizophrenia 2 Latuda - Analysis and Forecasts from 2011 to 2020   GlobalData, July 2011, Pages: 32 markets - Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets 1 1 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Schizophrenia 2 Risperdal Consta - Analysis and Forecasts from 2003 to 2020   GlobalData, July 2011, Pages: 31 period (2003-2020). The report also includes information on Schizophrenia market. This report is built using data and information sourced from GlobalData’s proprietary databases, primary and secondary Zyprexa - Analysis and Forecasts from 2002 to 2018   GlobalData, July 2011, Pages: 32 markets - Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets 1 1 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Schizophrenia 2 Clozapine - Analysis and Forecasts from 2002 to 2020   GlobalData, July 2011, Pages: 30 -2020). The report also includes information on Schizophrenia market. This report is built using data and information sourced from GlobalData’s proprietary databases, primary and secondary research using Company RG1678 - Analysis and Forecasts from 2014 to 2020   GlobalData, July 2011, Pages: 30 for currently marketed/pipeline drug for 2011-2020 for all seven major markets 1 1 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Schizophrenia 2.2 Symptoms 2.3 Schizophrenia Market 2 Invega - Analysis and Forecasts from 2007 to 2020   GlobalData, July 2011, Pages: 29 -2020). The report also includes information on Schizophrenia Disease market. This report is built using data and information sourced from GlobalData’s proprietary databases, primary and secondary research using Invega Sustenna - Analysis and Forecasts from 2009 to 2020   GlobalData, July 2011, Pages: 30 period (2009-2020). The report also includes information onSchizophrenia market. This report is built using data and information sourced from GlobalData’s proprietary databases, primary and secondary Schizophrenia Therapy Area Pipeline Report   Life Science Analytics, March 2011, Pages: 630 Schizophrenia Therapy Area Pipeline Report contains detailed information on the schizophrenia drug pipeline. This report provides insight into the pipeline status of schizophrenia drugs by company Zicronapine - Analysis and Forecasts from 2014 to 2020   GlobalData, July 2011, Pages: 28 markets - Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets 1 1 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Schizophrenia 2 Geodon - Analysis and Forecasts from 2002 to 2017   GlobalData, July 2011, Pages: 29 -2017). The report also includes information on Schizophrenia market. This report is built using data and information sourced from GlobalData’s proprietary databases, primary and secondary research using Company Seroquel XR - Analysis and Estimates from 2007 to 2020   GlobalData, July 2011, Pages: 29 -2020). The report also includes information on Schizophrenia market. This report is built using data and information sourced from GlobalData’s proprietary databases, primary and secondary research using Company Results:  First -   Prev -   1 -   2 -   3 -   4 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network